Literature DB >> 18478258

Morphological variability of lymphohistiocytic variant of anaplastic large cell lymphoma (former lymphohistiocytic lymphoma according to the Kiel classification).

Wolfram Klapper1, Matthias Böhm, Reiner Siebert, Karl Lennert.   

Abstract

According to the WHO classification, anaplastic large cell lymphoma (ALCL) is a distinct T-cell lymphoma entity with a number of morphological variants. The characteristic feature of lymphohistiocytic variant of ALCL according to the WHO classification is the abundance of histiocytes that exceed and mask the tumour cell population. In the current, study we reanalysed a historical series of 17 lymphomas, diagnosed as lymphohistiocytic lymphoma according to the criteria of the Kiel classification, with the presence of large purple macrophages (LPM) as the decisive finding for diagnosing this lymphoma subtype. We assessed the cellular composition of the tumour and correlated the results with the definition of lymphohistiocytic variant of ALCL given in the WHO classification. Although all cases in our cohort matched the criteria of ALCL according to the WHO, in 30% of the cases, the total amount of macrophages did not exceed the number of CD30-positive tumour cells. Our results indicate that the presence of LPM might be helpful to identify this subgroup of ALCL. Because the distinction of morphological subtypes of ALCL is of clinical relevance, improved criteria for subtyping ALCL are urgently needed that might include the presence LPM as one criteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478258     DOI: 10.1007/s00428-008-0616-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  15 in total

1.  Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma.

Authors:  K Pulford; B Falini; A H Banham; D Codrington; H Roberton; C Hatton; D Y Mason
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

Review 2.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells.

Authors:  Eva Geissinger; Tobias Odenwald; Seung-Sook Lee; Irina Bonzheim; Sabine Roth; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

4.  In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas.

Authors:  Lorena Passoni; Barbara Gallo; Elia Biganzoli; Roberta Stefanoni; Maura Massimino; Massimo Di Nicola; Alessandro M Gianni; Carlo Gambacorti-Passerini
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

5.  Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.

Authors:  S A Pileri; K Pulford; S Mori; D Y Mason; E Sabattini; G Roncador; M Piccioli; C Ceccarelli; P P Piccaluga; D Santini; O Leone; H Stein; B Falini
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

7.  Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

Authors:  Itziar Salaverria; Silvia Beà; Armando Lopez-Guillermo; Virginia Lespinet; Magda Pinyol; Birgit Burkhardt; Laurence Lamant; Andreas Zettl; Doug Horsman; Randy Gascoyne; German Ott; Reiner Siebert; Georges Delsol; Elias Campo
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

8.  A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.

Authors:  M C Kinney; R D Collins; J P Greer; J A Whitlock; N Sioutos; M E Kadin
Journal:  Am J Surg Pathol       Date:  1993-09       Impact factor: 6.394

9.  Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma.

Authors:  Christine Damm-Welk; Kerstin Busch; Birgit Burkhardt; Jutta Schieferstein; Susanne Viehmann; Ilske Oschlies; Wolfram Klapper; Martin Zimmermann; Jochen Harbott; Alfred Reiter; Willi Woessmann
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

10.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

View more
  1 in total

1.  New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2008-09       Impact factor: 0.196

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.